Skip to main content
. 2022 Jun;14(6):2187–2200. doi: 10.21037/jtd-22-534

Table 1. Echocardiographic measurements in mice treated with saline, Ang II, or moricizine cotreated.

Item Saline Ang II Ang II + moricizine P value
LVESD (mm) 2.28±0.19 2.70±0.18 4.42±0.16 0.243
LVEDD (mm) 3.67±0.14 3.84±0.20 3.72±0.18 0.781
LVESV (µL) 19.47±3.72 28.62±4.12 21.84±2.94 0.201
LVEDV (µL) 58.24±5.08 65.87±7.21 60.89±5.71 0.670
Stroke volume (µL) 38.77±2.48 37.25±4.21 39.06±3.47 0.924
EF % 68.65±3.99 57.13±3.38 65.23±1.96 0.065
FS % 38.57±2.35 29.87±2.02 35.45±1.96 0.066
CO (mL/min) 19.76±1.36 14.79±2.30 16.04±2.31 0.296
LAD (mm) 1.80±0.07 2.26±0.13 1.87±0.01 0.004

Data are presented means ± SEM; n=9 mice. LVESD, left ventricular end-systolic diameter; LVEDD, left ventricular end-diastolic diameter; LVESV, left ventricular end-systolic volume; LVEDV, left ventricular end-diastolic volume; EF, ejection fraction; FS, fractional shortening; CO, cardiac output; LAD, left atrial diameter; SEM, standard error of mean.